Royal Bank Of Canada Theratechnologies Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.01 $116 - $150	149 Added 0.88%	17,079 $14,000
Q1 2023 May 15, 2023	SELL	$0.72 - $1.12 $1,319 - $2,052	-1,833 Reduced 9.77%	16,930 $13,000
Q4 2022 Feb 14, 2023	BUY	$0.83 - $2.3 $1,626 - $4,508	1,960 Added 11.66%	18,763 $16,000
Q3 2022 Nov 14, 2022	BUY	$1.98 - $2.42 $1,613 - $1,972	815 Added 5.1%	16,803 $40,000
Q2 2022 Aug 15, 2022	SELL	$2.21 - $2.7 $17,766 - $21,705	-8,039 Reduced 33.46%	15,988 $36,000

Q1 2022 May 16, 2022	SELL	$2.37 - $3.24 $6,287 - $8,595	-2,653 Reduced 9.94%	24,027 $59,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $3.76 $13,029 - $16,777	4,462 Added 20.08%	26,680 $81,000
Q3 2021 Nov 15, 2021	SELL	$3.28 - $4.07 $813 - $1,009	-248 Reduced 1.1%	22,218 $83,000
Q2 2021 Aug 16, 2021	BUY	$3.43 - $3.96 $77,058 - $88,965	22,466 New	22,466 $87,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $135M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.